Status:

COMPLETED

Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography

Lead Sponsor:

University of Michigan

Conditions:

Breast Neoplasms

Breast Abnormalities

Eligibility:

FEMALE

30+ years

Phase:

EARLY_PHASE1

Brief Summary

The purpose of this study is to compare 3D mammography with digital mammography in women with dense breasts for the detection and evaluation of masses and/or breast cancer.

Eligibility Criteria

Inclusion

  • Females 30 years of age or older.
  • Dense Breasts.
  • Has undergone clinical two view mammogram and diagnostic breast imaging evaluation.
  • Suspicious or palpable mass and scheduled for biopsy.

Exclusion

  • Pregnant or lactating women.
  • Prior personal history of breast cancer.
  • Prior breast augmentation with implants or silicon injection. male patients.
  • No two view mammogram as part of breast imaging evaluation.
  • Breast density of almost entirely fatty/scattered fibroglandular densities.

Key Trial Info

Start Date :

April 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2013

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT00722059

Start Date

April 1 2006

End Date

October 1 2013

Last Update

February 3 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Michigan Health System

Ann Arbor, Michigan, United States, 48109

Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography | DecenTrialz